Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT.

Arch Gen Psychiatry. 1999 Jan;56(1):21-7.

PMID:
9892252
2.

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.

Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M.

Arch Gen Psychiatry. 1999 Jan;56(1):29-36.

PMID:
9892253
3.

A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.

Goff DC, Henderson DC, Evins AE, Amico E.

Biol Psychiatry. 1999 Feb 15;45(4):512-4.

PMID:
10071726
4.

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT.

Am J Psychiatry. 2007 Oct;164(10):1593-602.

PMID:
17898352
5.

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.

Rosse RB, Fay-McCarthy M, Kendrick K, Davis RE, Deutsch SI.

Clin Neuropharmacol. 1996 Oct;19(5):444-50.

PMID:
8889288
6.

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.

Tsai G, Lane HY, Yang P, Chong MY, Lange N.

Biol Psychiatry. 2004 Mar 1;55(5):452-6.

PMID:
15023571
7.

A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.

Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA, Abramovich Y, Amital D, Doron A, Konas S, Levkovitz Y, Liba D, Teitelbaum A, Mashiach M, Zimmerman Y.

J Clin Psychiatry. 2012 Jun;73(6):e728-34. doi: 10.4088/JCP.11m07031.

PMID:
22795211
8.

D-cycloserine added to clozapine for patients with schizophrenia.

Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT.

Am J Psychiatry. 1996 Dec;153(12):1628-30.

PMID:
8942463
9.

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.

Goff DC, Tsai G, Manoach DS, Coyle JT.

Am J Psychiatry. 1995 Aug;152(8):1213-5.

PMID:
7625475
10.

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.

Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G.

Biol Psychiatry. 2006 Sep 15;60(6):645-9. Epub 2006 Jun 14.

PMID:
16780811
11.

D-serine added to antipsychotics for the treatment of schizophrenia.

Tsai G, Yang P, Chung LC, Lange N, Coyle JT.

Biol Psychiatry. 1998 Dec 1;44(11):1081-9.

PMID:
9836012
12.

Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.

Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF.

Schizophr Res. 2008 Dec;106(2-3):320-7. doi: 10.1016/j.schres.2008.08.012. Epub 2008 Sep 16.

13.

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Horowitz A, Kelly D.

Br J Psychiatry. 1996 Nov;169(5):610-7.

PMID:
8932891
14.

IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.

D'Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J, Sturwold R, Bennett A, Karper LP, Zuzarte E, Charney DS, Krystal JH.

Biol Psychiatry. 2000 Mar 1;47(5):450-62.

PMID:
10704956
15.

The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers.

van Berckel BN, Lipsch C, Gispen-de Wied C, Wynne HJ, Blankenstein MA, van Ree JM, Kahn RS.

Psychopharmacology (Berl). 1998 Jul;138(2):190-7.

PMID:
9718289
16.

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.

Kramer MS, Last B, Getson A, Reines SA.

Arch Gen Psychiatry. 1997 Jun;54(6):567-72. Erratum in: Arch Gen Psychiatry 1997 Dec;54(12):1080.

PMID:
9193198
17.

Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.

Chen ZH, Wang GH, Wang XP, Chen RY, Wang HL, Yang MH, Huo YX, Mei HB.

Hum Psychopharmacol. 2008 Aug;23(6):465-70. doi: 10.1002/hup.958.

PMID:
18536066
19.

D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study.

van Berckel BN, Evenblij CN, van Loon BJ, Maas MF, van der Geld MA, Wynne HJ, van Ree JM, Kahn RS.

Neuropsychopharmacology. 1999 Aug;21(2):203-10.

Supplemental Content

Support Center